SCHEMBL3490683

SCHEMBL3490683

CCOC(=O)Oc1c(C)ncc2c1CO[C@H]2c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 1/20 0.38
ACHE P22303 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 5/20 0.35
LMNA P02545 4/20 0.35
ALDH1A1 P00352 4/20 0.35
TDP1 Q9NUW8 1/20 0.35
OPRK1 P41145 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
KMT2A Q03164 1/20 0.34
CACNA1D Q01668 1/20 0.34
ABCB11 O95342 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3488951 0.92 MAPT (0.35) HPGDMAPTLMNAALDH1A1KMT2A
SCHEMBL638386 0.92 MAPT (0.35) HPGDMAPTLMNAALDH1A1KMT2A
SCHEMBL3491675 0.88 MAPT (0.33) MAPTKMT2AMAPK1
SCHEMBL3490573 0.87 MAPT (0.33) ABCC1MAPTKMT2AMAPK1TP53
SCHEMBL636419 0.87 MAPT (0.33) ABCC1MAPTKMT2AMAPK1TP53
SCHEMBL3488954 0.87 MAPT (0.36) MAPTLMNAALDH1A1KMT2AMAPK1
SCHEMBL9662398 0.87 MAPT (0.36) MAPTLMNAKMT2AABCB11MAPK1
SCHEMBL638387 0.87 MAPT (0.36) MAPTLMNAALDH1A1KMT2AMAPK1
SCHEMBL3490680 0.86 MAPT (0.32) MAPTKMT2A
SCHEMBL13493946 0.86 MAPT (0.30) MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029678-A1 DIURETICS MERCK SHARP & DOHME CORP. 2010-02-04 US claimed
US-20100029678-A1 DIURETICS MERCK SHARP & DOHME CORP. 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029678-A1 DIURETICS NR3C2, REN, NR3C1 ABCC1 201/4885ACHE 2833/4885NPSR1 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.